A tool, called mitoDREADD-Gs, improves memory in Alzheimer's and dementia mouse models by boosting mitochondrial activity.

Sarepta Therapeutics said Friday that the deaths of two patients taking its marketed gene therapy Elevidys® (delandistrogene moxeparvovec-rokl), posted on a public FDA database and reported this ...

Sartorius Stedim Biotech and Nanotein Technologies plan to develop additional products for the expanding cell and gene therapy markets.

A non-opioid analgesic, called ADRIANA, targets α2B-adrenoceptors with promising Phase II results in Japan.

Researchers say the new concept that lithium deficiency could be a cause of Alzheimer’s disease points to a different therapeutic approach.

Agg-CLNP synergized with abatacept to delay RA-related inflammation and with dexamethasone to prevent flare-ups following steroid withdrawal.

In addition to cell line development, CHO Plus partnered to scale up Avid Bioservices' mAb production to meet industrial scale requirements.

Murine study finds eIF2A dependence emerges only after malignant transformation, suggesting a therapeutic window that may spare healthy tissues.

The Virtual Lab Team quickly designed nanobodies that bind to spike protein of recent SARS-CoV-2 strains.

The advances in these therapies will be of limited help to patients in Africa if we don’t do a better job of including them in clinical trials, funding researchers’ labs directly and fast ...

Large-scale study defines genetic architecture of stuttering; findings point to 48 genes associated and highlight neurological risk pathways.

Ivermectin is an effective strategy to control malaria transmission, according to a trial in Kenya, which showed a 26% reduction in new infections.